Abbott Laboratories (ABT) Other financing activities (2016 - 2022)

Abbott Laboratories' Other financing activities history runs 7 years deep, the most recent figure standing at $324.0 million for Q1 2022.

• In Q1 2022, Other financing activities rose 6.58% year-over-year to $324.0 million; the TTM figure through Sep 2025 stood at $324.0 million (up 427.27% YoY), while the FY2025 annual figure was -$82.0 million, changed N/A from the prior year.
• Other financing activities came in at $324.0 million for Q1 2022 at Abbott Laboratories, up from -$536.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $324.0 million in Q1 2022 to a low of -$536.0 million in Q4 2021.
• A 5-year average of $110.9 million and a median of $105.5 million in 2019 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities slumped 79.65% in 2018 and gained 24.08% in 2021, its largest moves.
• Abbott Laboratories' Other financing activities stood at $81.0 million in 2018, then rose by 4.94% to $85.0 million in 2019, then rose by 18.82% to $101.0 million in 2020, then sank by 630.69% to -$536.0 million in 2021, then soared by 160.45% to $324.0 million in 2022.
• According to Business Quant data, Other financing activities over the past three periods registered $324.0 million, -$536.0 million, and $113.0 million for Q1 2022, Q4 2021, and Q3 2021 respectively.

Peer Comparison